Mutations in AGPAT2, which is another gene involved in de novo triglyceride synthesis, is an accepted cause of congenital generalized lipodystrophy associated with extreme insulin resistance and early onset diabetes in humans [31], and the phenotype has been reproduced in agpat2-deficient mice [32]. The gene discussed is AGPAT2; the disease is generalized lipodystrophy.